UBA7 and neoplasm: Tumor reduction was observed in 19 of 32 (59%) patients with above-median UBA7 expression, compared with just 5 of 32 (16%) patients with below-median UBA7 expression (odds ratio [OR] = 0.13 [95% CI 0.03–0.47], p = 0.001; Figure 2C).